×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
Biomarker
disease
CTD_human
Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
26239085 2015
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
GeneticVariation
disease
BEFREE
In this study, by using polymerase chain reaction and fluorescence in situ hybridization techniques, we have showed that there is neither t(14;18)/IGH-BCL2 nor IGH gene rearrangement in 4 de novo IDCS without a concurrent or known history of a B-cell lymphoma, including follicular lymphoma, indicating that BCL2 chromosomal translocation is not a general feature of de novo IDCS .
20736747 2010
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
AlteredExpression
disease
BEFREE
Incidence of Epstein-Barr virus bcl-2 expression and chromosomal translocation t(14;18) in large cell lymphoma associated with paragranuloma (lymphocyte-predominant Hodgkin's disease).
8150454 1994
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
GeneticVariation
disease
BEFREE
The difference of bcl-2 rearrangement frequency between follicular, mixed and large cell lymphoma was also statistically significant (P = 0.012).
8449825 1993
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
GeneticVariation
disease
BEFREE
There was only one large-cell lymphoma with a bcl-2 rearrangement.
2200538 1990
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
GeneticVariation
disease
BEFREE
bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma .2648153 1989
×
Entrez Id: 596
Gene Symbol: BCL2
BCL2
0.350
Biomarker
disease
CTD_human
Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
3287162 1988
×
Entrez Id: 604
Gene Symbol: BCL6
BCL6
0.320
Biomarker
disease
CTD_human
Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
25543051 2015
×
Entrez Id: 604
Gene Symbol: BCL6
BCL6
0.320
AlteredExpression
disease
BEFREE
In the presence of EBV infection, BCL-6 expressing AIDS-LCL fails to express the latent membrane protein 1 (LMP1) antigen.
12055673 2002
×
Entrez Id: 604
Gene Symbol: BCL6
BCL6
0.320
GeneticVariation
disease
BEFREE
This study suggests that BCL6 rearrangement is primarily associated with large cell lymphoma , and that BCL2(-)BCL6(+) NHL could potentially be curable with modern combination chemotherapy.
9209377 1997
×
Entrez Id: 11200
Gene Symbol: CHEK2
CHEK2
0.300
Biomarker
disease
CTD_human
Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma.
26506619 2015
HLA-DRB1
0.300
Biomarker
disease
CTD_human
Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
22096508 2011
×
Entrez Id: 6470
Gene Symbol: SHMT1
SHMT1
0.300
Biomarker
disease
CTD_human
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
17119116 2007
×
Entrez Id: 875
Gene Symbol: CBS
CBS
0.300
Biomarker
disease
CTD_human
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
17119116 2007
×
Entrez Id: 2356
Gene Symbol: FPGS
FPGS
0.300
Biomarker
disease
CTD_human
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
17119116 2007
×
Entrez Id: 635
Gene Symbol: BHMT
BHMT
0.300
Biomarker
disease
CTD_human
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study.
17119116 2007
×
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.300
Biomarker
disease
CTD_human
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival.
17488658 2007
×
Entrez Id: 7037
Gene Symbol: TFRC
TFRC
0.300
Biomarker
disease
CTD_human
The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer.
16904380 2006
×
Entrez Id: 7298
Gene Symbol: TYMS
TYMS
0.300
Biomarker
disease
CTD_human
Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes.
16365025 2005
×
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300
Therapeutic
disease
CTD_human
High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.
11911406 2002
×
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
0.300
Biomarker
disease
CTD_human
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
11406608 2001
×
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.300
Therapeutic
disease
CTD_human
DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).
11486401 2001
×
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.300
Therapeutic
disease
CTD_human
Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study.
11732872 2001
×
Entrez Id: 2052
Gene Symbol: EPHX1
EPHX1
0.300
Biomarker
disease
CTD_human
Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
11406608 2001
×
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2
0.300
Therapeutic
disease
CTD_human
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
7515650 1994